Clinical Trial

Opioid, HIV and Immune System

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people opioid and non opioid users to understand how opioid affect the immune responses (body defenses against infection) to the flu vaccine.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-03-10; most recent amendment 2026-03-24.
Status change: Recruiting → Active, Not Recruiting 2026-03-19
Status change: Not Yet Recruiting → Recruiting 2020-12-02
Trial Details
NCT Number NCT04304768
Lead Sponsor University of Miami
Conditions Immune Defect
Enrollment 400 participants
Start Date 2020-11-18
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-27